Phibro Animal Health Corporation
NASDAQPhibro Animal Health Corporation heads into its May 7 earnings call with the CEO selling shares almost every trading day of the past two weeks — even as the stock surged to new highs. The insider angle is the story heading into this print. CEO Jack Bendheim sold shares on at least seven separate occasions between April 22 and April 30, raising roughly $1.5 million in total proceeds…
Snapshot as of 22 Jun 2026
Phibro Animal Health Corporation heads into its May 7 earnings call with the CEO selling shares almost every trading day of the past two weeks — even as the stock surged to new highs. The insider angle is the story…
Phibro Animal Health just reported fiscal Q3 results that beat on both top and bottom lines — and promptly raised full-year guidance — yet the CEO has spent the past two weeks trimming his position into every…
Phibro Animal Health Corporation reports its Q3 2026 results today, and the most conspicuous signal heading into the print is not a short seller — it's the CEO. Jack Bendheim, who controls 48% of the company, sold…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PAHC — free to start on ORTEX.
Sign up for free →Open PAHC on ORTEX